Bayer, Versant Invest $225M in Stem Cell Research – Bloomberg
Bloomberg |
Bayer, Versant Invest $225M in Stem Cell Research
Bloomberg Versant Ventures Managing Director Jerel Davis joins Bloomberg TV Canada's Amanda Lang to discuss why the venture capital firm chose Toronto for its big investment in stem cell research. (Source: Bloomberg) … |
